Who
Glenn Coleman
EVP & Chief Financial Officer
Company insider
Files Form 4 as: EVP & Chief Financial Officer, Charles River Laboratories International; CAO & CFO, Premier; Executive VP & CFO, Dentsply Sirona; Executive Vice President & COO, Integra LifeSciences Holdings; VP & Corporate Controller, Curtiss-Wright.
In numbers
- Trades disclosed
- 194
- Buys
- 3
- Sells
- 32
- Bought
- $312K
- Sold
- $9.5M
- Companies
- 5
- Companies where not an officer
- 0
- First trade
- 17 Nov 2008
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Bought | $2,97410 at $297.43 | filing |
| 29 May 2026filed 2 Jun 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $1.2M6,640 at $180.71 | filing |
| 29 May 2026filed 2 Jun 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $1.2M6,640 at $180.71 | filing |
| 1 May 2026filed 4 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $3.5M21,112 at $165.78 | filing |
| 1 May 2026filed 4 May 2026 | CRL Charles River Laboratories InternationalLife-science tools | SEC FORM 4 Code A | $3.5M21,112 at $165.78 | filing |
| 25 Nov 2025filed 26 Nov 2025 | Premier | SEC FORM 4 Code D | $4.6M161,464 at $28.25 | filing |
| 25 Nov 2025filed 26 Nov 2025 | Premier | SEC FORM 4 Code D | —32,018 at $0.00 | filing |
| 11 Nov 2025filed 12 Nov 2025 | Premier | SEC FORM 4 Code F | $480K17,026 at $28.17 | filing |
| 11 Nov 2025filed 12 Nov 2025 | Premier | SEC FORM 4 Code F | $109K3,874 at $28.17 | filing |
| 21 Aug 2025filed 22 Aug 2025 | Premier | SEC FORM 4 Code A | —32,018 at $0.00 | filing |
| 19 Aug 2025filed 20 Aug 2025 | Premier | SEC FORM 4 Code A | —15,001 at $0.00 | filing |
| 19 Aug 2025filed 20 Aug 2025 | Premier | SEC FORM 4 Code A | —23,888 at $0.00 | filing |
| 11 Nov 2024filed 12 Nov 2024 | Premier | SEC FORM 4 Code A | —143,475 at $0.00 | filing |
| 11 Oct 2024filed 15 Oct 2024 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | $30112.28 at $24.50 | filing |
| 11 Oct 2024filed 15 Oct 2024 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —375.28 at $0.00 | filing |
| 12 Jul 2024filed 15 Jul 2024 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | $29911.59 at $25.80 | filing |
| 12 Jul 2024filed 15 Jul 2024 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —404.92 at $0.00 | filing |
| 12 Apr 2024filed 15 Apr 2024 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | $2989.46 at $31.45 | filing |
| 12 Apr 2024filed 15 Apr 2024 | XRAY Dentsply SironaMedical Devices | SEC FORM 4 Code A | —302.44 at $0.00 | filing |
| 18 Mar 2024filed 19 Mar 2024 | XRAY Dentsply Sironaoption or derivative · Medical Devices | SEC FORM 4 Code A | $66K1,858.75 at $35.59 | filing |
News
Charles River Laboratories International (NYSE:CRL) versus VivoSim Labs (NASDAQ:VIVS) Head-To-Head ContrastCRL · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Glenn Coleman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.